IDiyas

For the Inventor, By the Inventor

Waltham, MA, United States of America

Jeremy Green

USPTO Granted Patents = 58 

 

 

Average Co-Inventor Count = 6.0

ph-index = 21

Forward Citations = 1,396(Granted Patents)

Forward Citations (Not Self Cited) = 1,187(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Burlinton, MA (US) (2007)
  • Burlngton, MA (US) (2010)
  • Burlington, MA (US) (2000 - 2012)
  • Rockville, MD (US) (2013 - 2015)
  • Waltham, MA (US) (2009 - 2021)

Company Filing History:

goldMedal57 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal1 out of 5 
 
Liminal Biosciences Limited
 patents

Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
58 patents (USPTO):
1. 12378229 - GPR84 antagonists and uses thereof (2025-08-05),
2. 11021465 - DNA-PK inhibitors (2021-06-01),
3. 11008305 - DNA-PK inhibitors (2021-05-18),
4. 10501439 - DNA-PK inhibitors (2019-12-10),
5. 10442791 - DNA-PK inhibitors (2019-10-15),
6. 10391095 - DNA-PK inhibitors (2019-08-27),
7. 10301304 - Selective inhibitor of phosphatidylinositol 3-kinase-gamma (2019-05-28),
8. 10076521 - DNA-PK inhibitors (2018-09-18),
9. 9925188 - DNA-PK inhibitors and uses thereof (2018-03-27),
10. 9878993 - DNA-PK inhibitors for treatment of cancer (2018-01-30),
11. 9592232 - DNA-PK inhibitors (2017-03-14),
12. 9376448 - DNA-PK inhibitors (2016-06-28),
13. 9296701 - DNA-PK inhibitors (2016-03-29),
14. 8987454 - Azaindoles useful as inhibitors of JAK and other protein kinases (2015-03-24),
15. 8921376 - Pyrrolopyridines useful as inhibitors of protein kinase (2014-12-30),

Title: The Innovator: Jeremy Green

Introduction:

Jeremy Green, a prolific inventor based in Waltham, MA, US, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 57 patents. His groundbreaking work in developing DNA-PK inhibitors has opened new possibilities in the treatment of various diseases and disorders.

Latest Patents:

Jeremy Green's latest patents revolve around DNA-PK inhibitors, showcasing his expertise in this area. These compounds show promise as effective inhibitors of DNA-PK, with potential applications in the treatment of a wide range of medical conditions. The pharmaceutical compositions comprising these compounds offer innovative solutions for combating diseases on a molecular level.

Career Highlights:

Throughout his career, Jeremy Green has demonstrated a keen focus on research and innovation. His tenure at companies like Vertex Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated has been marked by groundbreaking discoveries and advancements in the pharmaceutical industry. His dedication to pushing the boundaries of science has earned him a reputation as a forward-thinking inventor.

Collaborations:

Jeremy Green has collaborated with esteemed professionals in the field, including Albert Charles Pierce and Huai Gao. These partnerships have led to fruitful exchanges of ideas and expertise, further fueling Jeremy's innovative spirit. By working alongside top talents in the industry, he has been able to amplify the impact of his inventions and drive progress in the field of pharmaceutical research.

Conclusion:

In conclusion, Jeremy Green stands out as a visionary inventor whose contributions have had a profound impact on the world of pharmaceuticals. His pioneering work in developing DNA-PK inhibitors underscores his commitment to innovation and improving healthcare outcomes. With a remarkable track record of patents and a collaborative spirit, Jeremy Green is a driving force in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…